EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Biologicals and Fetal Cell Therapy for Wound and Scar Management

Nathalie Hirt-Burri, Albert-Adrien Ramelet, Wassim Raffoul, Anthony de Buys Roessingh, Corinne Scaletta, Dominique Pioletti, Lee Ann Applegate

ISRN Dermatology · 2011

DOI: 10.5402/2011/549870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Dermatology, 2011. Verfasst von Nathalie Hirt-Burri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Therapy Unit, Department of Musculoskeletal Medicine, University Hospital of Lausanne, CHUV/UNIL, PAV 03, 1011 Lausanne, Switzerland. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Few biopharmaceutical preparations developed from biologicals are available for tissue regeneration and scar management. When developing biological treatments with cellular therapy, selection of cell types and establishment of consistent cell banks are crucial steps in whole-cell bioprocessing. Various cell types have been used in treatment of wounds to reduce scar to date including autolog and allogenic skin cells, platelets, placenta, and amniotic extracts. Experience with fetal cells show that they may provide an interesting cell choice due to facility of outscaling and known properties for wound healing without scar. Differential gene profiling has helped to point to potential indicators of repair which include cell adhesion, extracellular matrix, cytokines, growth factors, and development. Safety has been evidenced in Phase I and II clinical fetal cell use for burn and wound treatments with different cell delivery systems. We present herein that fetal cells present technical and therapeutic advantages compared to other cell types for effective cell-based therapy for wound and scar management.

Autor:innen und Institutionen

  • Cellular Therapy Unit, Department of Musculoskeletal Medicine, University Hospital of Lausanne, CHUV/UNIL, PAV 03, 1011 Lausanne, Switzerland.

Zitieren

APA

Hirt-Burri, N., Ramelet, A. A., Raffoul, W., de Buys Roessingh, A., Scaletta, C., Pioletti, D., & Applegate, L. A. (2011). Biologicals and Fetal Cell Therapy for Wound and Scar Management. ISRN Dermatology. https://doi.org/10.5402/2011/549870

Vancouver

Hirt-Burri N, Ramelet AA, Raffoul W, de Buys Roessingh A, Scaletta C, Pioletti D, et al. Biologicals and Fetal Cell Therapy for Wound and Scar Management. ISRN Dermatology. 2011. doi:10.5402/2011/549870

BibTeX
@article{HirtBurri2011,
  author = {Hirt-Burri, Nathalie and Ramelet, Albert-Adrien and Raffoul, Wassim and de Buys Roessingh, Anthony and Scaletta, Corinne and Pioletti, Dominique and Applegate, Lee Ann},
  title = {Biologicals and Fetal Cell Therapy for Wound and Scar Management},
  journal = {ISRN Dermatology},
  year = {2011},
  doi = {10.5402/2011/549870}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche